News Release

Reducing pain in children receiving intravenous cannulation

Peer-Reviewed Publication

Canadian Medical Association Journal

Taddio and colleagues performed a double-blind randomized controlled trial to evaluate the effectiveness of liposomal lidocaine 4% cream in reducing the pain, duration and failure rate of intravenous cannulation in children.

Liposomal lidocaine improved the success rate of cannulation and reduced pain and procedure time. The authors suggest that liposomal lidocaine can be recommended for cutaneous analgesia in children.

In a related commentary, Pitetti describes recent changes in medical perceptions of how children experience pain and emphasizes the importance of decreasing or avoiding the pain experienced by children when undergoing diagnostic or therapeutic procedures.

###

p. 1691 Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial
– A. Taddio et al

Link to article: http://www.cmaj.ca/misc/press/pg1691.pdf

p. 1699 Do no harm – but first, do not hurt
– R. D. Pitetti

Link to article: http://www.cmaj.ca/misc/press/pg1699.pdf


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.